These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28506425)

  • 41. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
    J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the 7-valent pneumococcal conjugate vaccine on U.S. levofloxacin-resistant Streptococcus pneumoniae.
    Davies TA; Yee YC; Bush K; Sahm D; Evangelista A; Goldschmidt R
    Microb Drug Resist; 2008 Sep; 14(3):187-96. PubMed ID: 18707553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Emergence of quinolone-resistant strains in Streptococcus pneumoniae isolated from paediatric patients since the approval of oral fluoroquinolones in Japan.
    Takeuchi N; Ohkusu M; Hoshino T; Naito S; Takaya A; Yamamoto T; Ishiwada N
    J Infect Chemother; 2017 Apr; 23(4):218-223. PubMed ID: 28159338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
    Deshpande LM; Sader HS; Debbia E; Nicoletti G; Fadda G; Jones RN;
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):157-64. PubMed ID: 16423493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
    Balsalobre L; de la Campa AG
    Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.
    Pan XS; Ambler J; Mehtar S; Fisher LM
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2321-6. PubMed ID: 8891138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular epidemiology of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae in Seville.
    Iraurgui P; Torres MJ; Aznar J
    Enferm Infecc Microbiol Clin; 2012 Apr; 30(4):180-3. PubMed ID: 22365183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between mutations in parC and gyrA of clinical isolates of Streptococcus pneumoniae and resistance to ciprofloxacin and grepafloxacin.
    Stewart BA; Johnson AP; Woodford N
    J Med Microbiol; 1999 Dec; 48(12):1103-1106. PubMed ID: 10591164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
    Brown SD; Farrell DJ; Morrissey I
    J Clin Microbiol; 2004 Nov; 42(11):4980-7. PubMed ID: 15528684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of susceptibility testing to detect fluoroquinolone resistance mechanisms in Streptococcus pneumoniae.
    Richardson DC; Bast D; McGeer A; Low DE
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1911-4. PubMed ID: 11353652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea.
    Baek JY; Kang CI; Kim SH; Ko KS; Chung DR; Peck KR; Lee NY; Song JH
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):287-290. PubMed ID: 29540263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluoroquinolone resistance in Streptococcus pneumoniae: evidence that gyrA mutations arise at a lower rate and that mutation in gyrA or parC predisposes to further mutation.
    Gillespie SH; Voelker LL; Ambler JE; Traini C; Dickens A
    Microb Drug Resist; 2003; 9(1):17-24. PubMed ID: 12705679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy.
    Urban C; Rahman N; Zhao X; Mariano N; Segal-Maurer S; Drlica K; Rahal JJ
    J Infect Dis; 2001 Sep; 184(6):794-8. PubMed ID: 11517444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
    Skov R; Matuschek E; Sjölund-Karlsson M; Åhman J; Petersen A; Stegger M; Torpdahl M; Kahlmeter G
    J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluoroquinolone resistance in Streptococcus pneumoniae from a university hospital, Thailand.
    Srifuengfung S; Tribuddharat C; Chokephaibulkit K; Comerungsee S
    J Med Assoc Thai; 2010 Nov; 93 Suppl 5():S35-9. PubMed ID: 21298832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.
    Piekarska K; Wołkowicz T; Zacharczuk K; Rzeczkowska M; Chróst A; Bareja E; Olak M; Gierczyński R
    Int J Antimicrob Agents; 2015 Mar; 45(3):238-43. PubMed ID: 25468717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
    Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
    Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substitutions of Ser83Leu in GyrA and Ser80Leu in ParC Associated with Quinolone Resistance in Acinetobacter pittii.
    Gu DX; Hu YJ; Zhou HW; Zhang R; Chen GX
    Microb Drug Resist; 2015 Jun; 21(3):345-51. PubMed ID: 25514581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae from Asian countries: ANSORP study.
    Oh WS; Suh JY; Song JH; Ko KS; Jung SI; Peck KR; Lee NY; Yang Y; Chongthaleong A; Chiu CH; Kamarulzaman A; Parasakthi N; Lalitha MK; Perera J; Yee TT; Kumarasinghe G; Carlos CC;
    Microb Drug Resist; 2004; 10(1):37-42. PubMed ID: 15140392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dog/cat-origin quinolone-resistant Streptococcus agalactiae isolates with point mutations in quinolone resistance-determining regions: Relatedness with clonal complex 10.
    Maeda T; Tsuyuki Y; Goto M; Yoshida H; Fujita T; Takahashi T
    J Infect Chemother; 2022 Mar; 28(3):389-395. PubMed ID: 34848122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.